1999
DOI: 10.1016/s0024-3205(99)00237-4
|View full text |Cite
|
Sign up to set email alerts
|

The effect of therapeutic drugs and other pharmacologic agents on activity of porphobilinogen deaminase, the enzyme that is deficient in intermittent acute porphyria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
3
0
1

Year Published

2003
2003
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 16 publications
0
3
0
1
Order By: Relevance
“…PPIX is often used in PDT because it is not only effective, but it also selectively accumulates in certain tumor cells, one probable reason being that another enzyme involved in the biosynthesis of heme (5), porphobilinogen deaminase (PBGD), has a higher activity in certain tumor cells than in healthy cells (6). Other enzymes, such as AS and ferrochelatase (7,8), also seem to have differential activity in healthy and tumor cells, and may also contribute to the increased concentration of PPIX in tumor cells compared with neighboring healthy tissue (9).…”
Section: Introductionmentioning
confidence: 99%
“…PPIX is often used in PDT because it is not only effective, but it also selectively accumulates in certain tumor cells, one probable reason being that another enzyme involved in the biosynthesis of heme (5), porphobilinogen deaminase (PBGD), has a higher activity in certain tumor cells than in healthy cells (6). Other enzymes, such as AS and ferrochelatase (7,8), also seem to have differential activity in healthy and tumor cells, and may also contribute to the increased concentration of PPIX in tumor cells compared with neighboring healthy tissue (9).…”
Section: Introductionmentioning
confidence: 99%
“…[53][54][55] Sulfonamide-containing antibiotics, such as sulfamethoxazole and sulfisoxazole, have been considered to be risky for use in patients with AHP according to the American Porphyria Foundation Drug Database [https://porph yriaf ounda tion.org/drugd ataba se/]; however, in our LMH cell system, neither of these drugs led to excess PP accumulation, even in the presence of DFO (Figure 2). Indeed, our recent [November 3, 2021] PubMed searches on "sulfisoxazole AND acute porphyria" yielded only one citation, 56 which concluded that sulfisoxazole did not affect the activity of hydroxymethylbilane synthase in human erythrocytes or rat livers. A search on" sulfamethoxazole AND acute porphyria" did not yield any citations.…”
Section: Discussionmentioning
confidence: 99%
“…Taşikardisi ve hipertansiyonu propranolol ve enapril tedavisi ile kontrol altına alındı. Bu hastalarda atak esnasında görülen afebril nöbetlere müdahale etmek için kullanılan antikonvülzanlar hayati tehlike yaratabilir (5). Zaten respiratuar kas güçsüzlüğü olan porfiria olgularının antikonvülzan ile solunumu deprese olup, gelişen solunum yetmezliği ölüm nedeni olabilir.…”
Section: Discussionunclassified